Retatrutide 20mg Subcutaneous Injection Pre-Filled Pen

The Retatrutide 20mg Pen is an advanced, multi-action investigational peptide designed for metabolic research and clinical evaluation in weight management and type 2 diabetes. Dubbed the “Triple G” molecule, retatrutide represents the next generation of metabolic therapies by targeting three distinct hormone pathways to optimize fat breakdown and appetite regulation.

How Retatrutide 20mg Works

Unlike traditional single-receptor treatments, retatrutide is a single, synthetic peptide that acts as a triple-hormone receptor agonist. It mimics three naturally occurring incretin hormones:

GLP-1 (Glucagon-like peptide-1): Delays gastric emptying and suppresses appetite, helping patients feel full longer.

GIP (Glucose-dependent insulinotropic polypeptide): Enhances insulin secretion, reduces overall food intake, and optimizes fat metabolism.

Glucagon (GCG): Increases energy expenditure and directly stimulates the liver to burn stored body fat.

Key Features

Superior Weight Loss Efficacy: Phase 2 clinical data demonstrates average weight reductions up to 24.2% over 48 weeks, outperforming existing dual-agonist and single GLP-1 therapies.

Glycemic & Metabolic Control: Promotes substantial reductions in HbA1c levels, improves fasting plasma glucose, and aids in reducing visceral fat.

User-Friendly Delivery: Engineered as a pre-filled, multi-dose mechanical pen for precise, low-discomfort subcutaneous injection.

Convenient Dosing Schedule: Formulated for once-weekly dosing to ensure steady therapeutic absorption and maximum adherence.